Navidea Biopharmaceuticals Inc (NAVB)

[42Delta]

The "$10M" was just a ballpark. Navidea sold to Crede roughly 2.50-3.00. PM had to sell their 10M shares a few months later at roughly 1.50-2.00. resulting in roughly $10M of lost profits to PM since they were side-stepped. Suggest reading the P-share agreement and the significant restrictions imposed by PM on Navidea regarding secondary offerings by the company which net greater than $10M. As for 4694, IMO it's their best shot at significant future appreciation - I hope it kept as a priority. I would anticipate very noticeable changes ahead once MG is active as CEO June 1st. These announcements will likely occur prior to the July annual meeting and BOD voting. BOL